Keyphrases
Phase II Trial
100%
Breast Cancer Risk Reduction
100%
Soy Isoflavones
100%
Isoflavone Supplementation
100%
Ki-67 Index
80%
Breast
60%
Placebo
40%
Nipple Aspirate Fluid
40%
Fine-needle Aspiration
40%
Epithelial Ingrowth
40%
Between-group
40%
Postmenopausal Women
20%
Genistein
20%
Treatment Effect
20%
High Risk
20%
Adverse Effects
20%
Epithelial Cells
20%
Breast Cancer Progression
20%
Westerners
20%
Hormone Levels
20%
Breast Cancer Prevention
20%
Proliferation Apoptosis
20%
Protein Level
20%
Lack of Efficacy
20%
Between-group Difference
20%
Atypia
20%
High-risk Adults
20%
Estrogenic Effect
20%
Statistical Test
20%
Quantitative Reverse Transcriptase PCR
20%
Cytological Atypia
20%
Group Transformation
20%
Fluid Parameters
20%
Proliferation Effect
20%
Biochemistry, Genetics and Molecular Biology
Risk Reduction
100%
Isoflavone
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
33%
Statistical Test
33%
Premenopause
33%
Blood Plasma
33%
Genistein
33%
Programmed Cell Death
33%
Neuroscience
Isoflavone
100%
Placebo
66%
Epithelial Cells
33%
Adverse Effect
33%
Blood Plasma
33%
Reverse Transcription Polymerase Chain Reaction
33%
Genistein
33%
Programmed Cell Death
33%
Food Science
Isoflavones
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%